KRISTIN WATRAS: Open Payments
NPI 1619597002 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 22 payments from 8 companies in 2025. Trend: 2023 $590 · 2024 $466 · 2025 $530
Food & beverage: $430Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $197 |
| Sumitomo Pharma America, Inc. | 5 | $111 |
| Biogen, Inc. | 4 | $80 |
| Organon LLC | 2 | $42 |
| CooperSurgical, Inc. | 2 | $32 |
| Teleflex LLC | 1 | $30 |
| PFIZER INC. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
Products named: MYFEMBREE, Veozah, ZURZUVAE, Paragard T 380A, QUIKCLOT, NEXPLANON, COMIRNATY, JADA SYSTEM.
Industry payments across AZ — which companies pay providers there.
